NYAS Conferences
New York Academy of Sciences
left end
Search
divider divider feedback right end
Annals of the New York Academy of Sciences Annals of the New York Academy of Sciences login

Main

Browse Volumes

Forthcoming Volumes

Annals PrePrints

Annals Extra

E-mail Alerts

Subscriptions & Orders

New Proposals

Author Guidelines

About Annals

Help

Get free Annals volume as a NYAS member: http://www.nyas.org/annalsreaderhw
Issue 1073 coverPheochromocytoma: First International Symposium Volume 1073 published August 2006
Ann. N.Y. Acad. Sci. 1073: 94–103 (2006). doi: 10.1196/annals.1353.010
Copyright © 2006 by the New York Academy of Sciences
description | purchase volume purchase this volume

This Volume
Table of Contents
Description
This Article
Full Text
Full Text (PDF)
Services
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Citing Articles
Citing Articles via HighWire
Citing Articles via Google Scholar
Google Scholar
Articles by BORNSTEIN, S. R
Articles by GIMENEZ-ROQUEPLO, A.-P.
Search for Related Content
PubMed
PubMed Citation
Articles by BORNSTEIN, S. R
Articles by GIMENEZ-ROQUEPLO, A.-P.

Genetic Testing in Pheochromocytoma

Increasing Importance for Clinical Decision Making

STEFAN R BORNSTEINa AND ANNE-PAULE GIMENEZ-ROQUEPLOb

a Carl Gustav Carus University Hospital, Department of Medicine, 01307 Dresden, Germany b Université René Descartes, Faculté de Médecine, Département de Génétique, Hôpital Européen Georges Pompidou, Paris, France

Key Words: genetics • pheochromocytoma • RET • VHL • SDH

Address for correspondence: Stefan R. Bornstein, Department of Medicine, Technical University of Dresden, Fetscherstrasse 74, 01307 Dresden, Germany. Voice: +49/3514585955; fax: +49/3514586398  e-mail: Stefan.Bornstein{at}uniklinikum-dresden.de

Hereditary pheochromocytomas and paragangliomas are caused by germline mutations in syndrome-associated genes. This includes multiple endocrine neoplasia Type 2 (MEN 2) caused by mutations in the RET proto-oncogene, von Hippel–Lindau (VHL) syndrome due to mutations of the VHL gene, neurofibromatosis Type I (NF1) caused by mutations of the NF1 gene, and pheochromocytoma/paraganglioma syndromes due to mutations in genes encoding the succinate dehydrogenase subunits D (SDHD) and B (SDHB). At the First International Symposium on Pheochromocytoma (ISP2005) organized by the National Institutes of Health, a panel of specialist clinicians and scientists from around the world addressed the topic of genetic testing in pheochromocytoma patients. This review summarizes the discussions and conclusions of the panel and provides a recommendation for evidence-based management of genetic testing in these patients and their families. A pragmatic algorithm is presented, taking into account patient age, tumor location (extra-adrenal, intra-adrenal, unilateral, and bilateral), biochemical presentation, and financial costs. This was based on cumulative frequencies ranging from 7.5% to 29% for germline mutations in four genes (RET, VHL, SDHB, and SDHD) in patients with apparently sporadic pheochromocytomas. This algorithm will need to be validated by further genetic analysis, multicenter studies, and long-term observations.




This article has been cited by other articles:


Home page
J EndocrinolHome page
S. Cleary, J. K Phillips, T.-T. Huynh, K. Pacak, A. G Elkahloun, J. Barb, R. A Worrell, D. S Goldstein, and G. Eisenhofer
Neuropeptide Y expression in phaeochromocytomas: relative absence in tumours from patients with von Hippel-Lindau syndrome
J. Endocrinol., May 1, 2007; 193(2): 225 - 233.
[Abstract] [Full Text] [PDF]



footerLeft footerRight